A PYMNTS Company

U.S.: Watson Pharmaceutical confirms favorable ruling in antitrust litigation

By  |  October 1, 2012

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The court found that the plaintiffs’ claims were unsustainable because the underlying patent litigation was not objectively baseless and did not constitute sham litigation. The court had previously granted Watson’s motion to dismiss all claims asserted by the Federal Trade Commission concerning the same settlement. 

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Sacbee

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.